Drug Used in MRI Scans Can Be Dangerous
Contrast agents containing gadolinium are given to patients before they undergo MRI (magnetic resonance imaging) scans. The contrast agents improve the visibility of internal structures so that doctors can "read" what is inside a patient's body.
Not every patient can safely use gadolinium-based contrast agents. Those with kidney or liver problems are at risk of developing nephrogenic systemic fibrosis (NSF), a painful, life-threatening condition.
If gadolinium caused NSF, the circumstances should be investigated.
The attorneys at Girardi | Keese in California have experience investigating and solving tough medical issues. Did medical professionals have the information they needed about the dangers of gadolinium? Did drug manufacturers put proper warnings on the contrast agents?
Gadolinium-based contrast agents used in the U.S. include Magnevist, Omniscan, OptiMARK, MultiHance and Prohance.
NSF, a gadolinium side effect, has no consistently effective treatment.
NSF causes skin and connective tissue to thicken. The thickening inhibits normal movement of joints and can lead to broken bones. Internal organs can also get thick and tough, losing their flexibility. The disease looks and feels awful.
Our product liability lawyers welcome questions and concerns about patients who are suffering from NSF brought on by gadolinium-based contrast agents. We have extensive experience with pharmaceutical litigation and have access to medical experts familiar with NSF. Contact us for a consultation with an attorney at our law firm.
